Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.16 USD
Change Today 0.00 / 0.00%
Volume 137.0K
BTX On Other Exchanges
Symbol
Exchange
BTX is not on other exchanges.
As of 4:15 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Walter Funk Ph.D.

Former Vice President of Stem Cell Technology and Research, BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 4 different organizations across 5 different industries.

See Board Relationships
55--

Background*

Dr. Walter Funk, Ph.D. served as Vice President of Stem Cell Research and Technology at BioTime, Inc. since August 2009. Dr. Funk participates in the management of BioTime's team of scientists developing numerous products from human embryonic stem cells for use in research and in novel therapies for human diseases. Dr. Funk is an experienced biotechnology professional, having held both senior technical and executive research positions over the past 15 years. Dr. Funk ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Director
Director
Director

Education*

Post-Doctoral Training
University of Texas Southwestern Medical Center - Dallas
PhD
University Of British Columbia
BS
University Of British Columbia

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $3.16 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Ocata Therapeutics, Inc.
$243.3K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
$651.2K
Yokoyama Chikafumi Ph.D.Chief Executive Officer, President and Representative Director
ReproCELL, Inc.
--
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$469.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.